Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01626547
What this trial is testing

Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnaemiaSolid TumoursMalignant Lymphomas+1 more
Hospira, now a wholly owned subsidiary of Pfizer 291
Early research (Phase 1)Study completedNCT05383703
What this trial is testing

Clinical Study of MNC-168 Enteric-coated Capsule in the Treatment of Advanced Intestinal Solid Tumor

Who this might be right for
Advanced Malignant Solid Tumors
Moon (Guangzhou) Biotechnology Co., Ltd. 12
Early research (Phase 1)Study completedNCT01156870
What this trial is testing

First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid Tumor

Who this might be right for
Neoplasm Malignant
Sanofi 114
Large-scale testing (Phase 3)Ended earlyNCT04588246
What this trial is testing

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more
NRG Oncology 19
Early research (Phase 1)Active Not RecruitingNCT06571422
What this trial is testing

Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd. 59
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Not applicableActive Not RecruitingNCT04447222
What this trial is testing

Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

Who this might be right for
COVID-19 InfectionMalignant Solid Neoplasm
M.D. Anderson Cancer Center 1,242
Early research (Phase 1)Study completedNCT04908046
What this trial is testing

HMPL-295S1 in Patients With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Hutchmed 47
Testing effectiveness (Phase 2)Looking for participantsNCT06320405
What this trial is testing

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm+1 more
OHSU Knight Cancer Institute 38
Very early researchEnded earlyNCT05271279
What this trial is testing

OVV-01 Injection in Combination With IBR900 Cell Injection in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Solid TumorRelapsed/Refractory Lymphoma
Beijing Boren Hospital 2
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Testing effectiveness (Phase 2)Looking for participantsNCT06650566
What this trial is testing

Study of LM-299 in Subjects Advanced Malignant Tumors

Who this might be right for
Malignant Tumors
LaNova Medicines Limited 108
Early research (Phase 1)UnknownNCT05198752
What this trial is testing

Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Stemirna Therapeutics 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04089358
What this trial is testing

Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Children's Oncology Group 387
Early research (Phase 1)Study completedNCT02540876
What this trial is testing

Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant NeoplasmSolid NeoplasmUnresectable Malignant Neoplasm
University of Chicago 12
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05554341
What this trial is testing

Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial

Who this might be right for
Metastatic Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05722288
What this trial is testing

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Who this might be right for
Localized Prostate CarcinomaLocally Advanced Cervical CarcinomaLocally Advanced Rectal Carcinoma+15 more
City of Hope Medical Center 49
Early research (Phase 1)Study completedNCT00130169
What this trial is testing

Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies

Who this might be right for
Cancer, Malignant Tumors
Eisai Inc. 30
Early research (Phase 1)Study completedNCT03525925
What this trial is testing

Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center 16
Next Page